<Industry Awareness and Future Trends> The Reality of Clinical Trial Drug Supply During the COVID-19 Pandemic
A report on a survey conducted with 234 individuals engaged in clinical supply and operations regarding the advantages and potential barriers of DtP in current and future clinical trials.
The ideal model for remote clinical trials such as DtP and StP is to be flexible and accurately address the needs of patients and the protocol. With Catalent's "FlexDirect" Direct-to-Patient service, sponsors can make strategic choices flexibly. In addition to consistent supply support from Catalent, including traditional site shipments, site-to-patient shipments (StP), and direct-to-patient shipments (DtP), customized support for specific needs (such as emergency shipments) is also possible. Patient needs vary each time depending on the situation. This "FlexDirect" Direct-to-Patient service model allows for flexible responses to any situation. More detailed information is also available here: clinical.catalent.com/solutions/flexdirect-direct-to-patient-services/
Inquire About This Product
basic information
Catalent Pharma Solutions is a development and manufacturing partner for pharmaceuticals and health supplements. Headquartered in New Jersey, USA, we leverage an extensive global network with over 30 locations worldwide to assist in formulation across a diverse range of categories and dosage forms, from small molecule drugs to biopharmaceuticals, and from soft capsules to injectables. Our Japanese subsidiary, Catalent Japan Co., Ltd., has been in operation for over 40 years and has development and manufacturing capabilities for soft capsules of pharmaceuticals and health supplements at our Kakegawa plant in Shizuoka Prefecture. With 85 years of experience in soft capsule manufacturing technology, along with the expertise and achievements cultivated through long-term operations in Japan, our global network supports domestic and international know-how and information to assist in your formulation development and manufacturing. Dosage forms not manufactured in Japan can also be supported at our globally deployed manufacturing sites. Additionally, in Japan, the Kakegawa plant is equipped with a base for clinical trial-related services, offering a variety of services from project management to packaging, storage, and distribution of clinical trial drugs. We are also planning to open a GMP site in Shiga Prefecture soon.
Price range
Delivery Time
Applications/Examples of results
Storage, distribution, collection, and disposal of investigational drugs.
Company information
The name Catalent combines "Catalyst" and "Talent." We meet our customers' needs at every stage of formulation, from the development of pharmaceuticals and health products to delivery technologies, clinical trial-related services, and supply solutions. Our company is equipped with extensive expertise and experience, innovative technologies, and a wide range of services that contribute to rapid market entry, improved product performance, and reliable manufacturing and packaging.
